Take Action
Every woman who speaks openly about her Lipedema makes it easier for the next woman to be believed. That is what an Elora ambassador does.
An Elora ambassador is a woman with Lipedema who is willing to share her experience, support others, and advocate in her own community. Ambassadors are not experts or spokespeople. They are people who know what living with Lipedema is like, and are prepared to say so. The impact of peer advocacy in chronic illness is well-evidenced. If you are at a stage where you want to use your experience to help others, this is how.
Lipedema is a condition that has advanced because of the women who would not let it be ignored.
Every major development of the past twenty years (NICE NG203, ICD-11 recognition, the US Standard of Care, the growing research base) has been shaped by the consistent, sustained visibility that patients and patient organisations created. Researchers study conditions that are visibly in need of research. Policymakers act on conditions that constituents are raising with them. Doctors update their practice when patients present with information and refuse to accept dismissal.
The Elora Ambassador programme is how we formalise and support that role.
An ambassador does not need to have a public profile, a social media following, or experience in advocacy. The most important thing an ambassador does is be willing to talk about Lipedema honestly in their own sphere of influence.
That sphere might be small. It might be your GP practice, your local online community, your family, your colleagues. It might be larger: a podcast, a local news outlet, a community group. The scale does not matter. The honesty does.
Ambassadors are asked to:
Clinical information is necessary, but it is not sufficient. Women who have been dismissed for years, who have internalised the message that their symptoms are their fault, who are approaching a new doctor with a mixture of hope and exhaustion: they often need to hear from someone who has been in that position and come through it.
That is not something Elora as a platform can provide. It is something that another woman can provide, and it is something that has a measurable effect.
Research consistently shows that peer support in chronic illness reduces isolation, improves coping, and in some conditions leads to direct health improvements. In Lipedema specifically, the patient community has historically been the primary source of information for newly diagnosed women, long before health services were equipped to help. The ambassador programme builds on that tradition with structure and support.
Ambassadors are peers, not experts. They are not expected to answer clinical questions or advise other women on treatment choices. If those questions come up, the right response is to point to the information on Elora, to suggest the woman speak to a specialist, or simply to say “I do not know.”
That honesty is part of what makes peer support effective. An ambassador who says “I cannot tell you what treatment is right for you, but I can tell you what helped me and where I found the best information” is being genuinely useful, and is not stepping into a role they have not been trained for.
You do not need to be at peace with your diagnosis. You do not need to be in a good place with your body. You do not need to be free of pain or certain about what the future holds.
What you need is a willingness to be honest about what you have been through, and to use that honesty in service of the women who are at an earlier point on the same road.
If that is something you can offer, use the contact form below. We will get back to you with what the role involves, what support we provide to ambassadors, and how we match ambassadors with the women who need them.
Evidence rating: Emerging for structured peer advocacy programmes in Lipedema specifically. Peer support in chronic illness more broadly has strong evidence: it reduces isolation, improves coping, and in several conditions, leads to measurable health improvements. In Lipedema, the advocacy community has been central to every major policy advance of the past decade.
Research on patient advocacy in rare and under-recognised conditions consistently identifies patient voices as a key driver of clinical recognition and research investment, as documented in reviews including the 2025 npj Metabolic Health and Disease paper and the 2025 PMC progress review. The Elora Ambassador programme formalises that role.
You do not have to be recovered, or positive, or confident to be an ambassador. You do not have to have a diagnosis for a specific number of years, or have tried every treatment, or know every piece of research. What you need is a willingness to be honest about your experience and to use it in service of the women who come after you. If that sounds like something you could do, we would like to hear from you.